Diagnostic evaluation of Graves' ophthalmopathy
- PMID: 3065079
Diagnostic evaluation of Graves' ophthalmopathy
Abstract
The important questions to be answered in the course of decision-making in patients with Graves' ophthalmopathy include the following: 1. Is the eye problem owing to Graves' ophthalmopathy? If not, the cause of the eye problem must be sought. 2. Does the patient have serious medical problems apart from the thyroid and the eyes? Define type and severity, and risk to life and well-being. Do they preclude anesthesia or steroid therapy? 3. Is the patient euthyroid? Define thyroid abnormality and treat. 4. Is the eye problem the highest medical priority for the patient and the physician? If not, treat the highest priority, then return to the eyes. 5. Which particular manifestations of Graves' ophthalmopathy are the most troublesome to the patient? Establish priorities according to need and rational order for surgical procedures. 6. How have the eyes been treated in the past? What has been successful? What side effects have resulted? In the evaluation of a patient with possible Graves' ophthalmopathy, no single clinical or laboratory feature is necessary or pathognomonic of the disorder. The sufficient findings for a diagnosis are a matter of clinical judgment. Several diagnostic tools including CT scanning, various ophthalmologic examinations, and studies of thyroid function are available. The physician must use these tools, along with clinical judgment, to establish the diagnosis with maximum certainty. Following this, the particular manifestations of the disease that are most troublesome to the patient must be carefully defined and assessed. Only then can the treatment be optimally tailored to the patient's needs.
Similar articles
-
Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.Arch Intern Med. 1990 May;150(5):1098-101. Arch Intern Med. 1990. PMID: 1691908
-
[Treatment of Grave's ophthalmopathy with high doses of corticosteroids].Srp Arh Celok Lek. 2000 May-Jun;128(5-6):179-83. Srp Arh Celok Lek. 2000. PMID: 11089418 Serbian.
-
Graves' ophthalmopathy.J Ophthalmic Nurs Technol. 1990 Jan-Feb;9(1):16-21. J Ophthalmic Nurs Technol. 1990. PMID: 2313706
-
Graves' ophthalmopathy--a clinical review.Aust N Z J Ophthalmol. 1990 Aug;18(3):239-42. Aust N Z J Ophthalmol. 1990. PMID: 2261168 Review.
-
Graves' ophthalmopathy and 131I therapy.Q J Nucl Med. 1999 Dec;43(4):307-12. Q J Nucl Med. 1999. PMID: 10731781 Review.
Cited by
-
The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.Trans Am Ophthalmol Soc. 1994;92:477-588. Trans Am Ophthalmol Soc. 1994. PMID: 7886878 Free PMC article.
-
Graves' ophthalmopathy.West J Med. 1993 Jun;158(6):591-5. West J Med. 1993. PMID: 8337853 Free PMC article. Review.
-
Serum microRNA as a potential biomarker for the activity of thyroid eye disease.Sci Rep. 2023 Jan 5;13(1):234. doi: 10.1038/s41598-023-27483-w. Sci Rep. 2023. PMID: 36604580 Free PMC article.
-
Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.J Endocrinol Invest. 1991 Nov;14(10):853-60. doi: 10.1007/BF03347943. J Endocrinol Invest. 1991. PMID: 1802923 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Miscellaneous